LIPID THERAPEUTICS
Novel therapies for inflammatory diseases of the digestive system
LIPID THERAPEUTICS
Industry:
Biotechnology Life Science Medical Therapeutics
Address:
Heidelberg, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.lipid-therapeutics.com
Total Employee:
1+
Status:
Closed
Technology used in webpage:
Euro Amazon Apache 2.4 Ubuntu Amazon Ohio Region Google DNS Google Domains Google Cloud DNS Adobe GoLive
Similar Organizations
Exponential Biotherapies
Exponential Biotherapies develops therapeutics to attenuate overreactions of the immune system.
Official Site Inspections
http://www.lipid-therapeutics.com
- Host name: 142.234.71.47
- IP address: 142.234.71.47
- Location: Burbank United States
- Latitude: 34.1718
- Longitude: -118.32
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 91506
More informations about "Lipid Therapeutics"
Lipid nanoparticles for mRNA delivery | Nature Reviews Materials
Aug 10, 2021 · Lipid nanoparticles have successfully entered the clinic for the delivery of mRNA; in particular, lipid nanoparticle–mRNA vaccines are now in clinical use against coronavirus …See details»
Nanostructured lipid carriers as a drug delivery system: A ...
Sep 23, 2024 · Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) are advanced lipid-based drug delivery systems designed to improve the bioavailability and …See details»
Liquid crystalline inverted lipid phases encapsulating siRNA …
Feb 12, 2024 · Efficient cytosolic delivery of RNA molecules remains a formidable barrier for RNA therapeutic strategies. Lipid nanoparticles (LNPs) serve as state-of-the-art carriers that can …See details»
Comprehensive analysis of lipid nanoparticle formulation and ...
In this review article, we describe the lipid-based delivery systems, focusing on lipid nanoparticles, the need of their use, provide a comprehensive analysis of each component, and highlight the …See details»
Lipid Nanoparticles─From Liposomes to mRNA …
Jun 28, 2021 · Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of the COVID-19 mRNA …See details»
Lipid-Based Nanoparticles for Drug/Gene Delivery: An …
Aug 21, 2023 · In this review, we introduce the main types of LNPs used in drug formulations such as liposomes, nanoemulsions, solid lipid nanoparticles, nanostructured lipid carriers, and lipid polymer hybrid nanoparticles, focusing …See details»
A complete guide to understanding Lipid nanoparticles …
All the current FDA-approved formulations are composed of 4 lipids (glycerophospholipids, cationic lipids, sterol lipids, and PEGylated lipids) each having a very specific role to encapsulate the oligonucleotides into aqueous …See details»
Cooking up a breakthrough: Engineers refine lipid nanoparticles …
5 days ago · Engineers have cooked up a new way to improve mRNA delivery, developing an optimal 'recipe' for ionizable lipids -- key ingredients in lipid nanoparticles (LNPs), the …See details»
Atomistic Insights into Organization of RNA-Loaded …
Jan 5, 2023 · RNA-based therapies have shown promise in a wide range of applications, from cancer therapy, treatment of inherited diseases to vaccination. Encapsulation of RNA into ionizable lipid (IL) containing lipid nanoparticles …See details»
From lipids to lipid nanoparticles to mRNA vaccines
Sep 21, 2021 · Lipid nanoparticles are essential to mRNA vaccines. The groundwork for lipid-based drug delivery systems was laid more than 40 years ago in the lab of Pieter Cullis, …See details»
High-Throughput Synthesis and Characterization of …
Mar 3, 2022 · Next-generation lipid nanoparticles (LNPs) have the capacity to dramatically improve the intracellular delivery and release of functionally active, nucleic acid-based therapeutics.See details»
RNA-based therapy in the management of lipid disorders: a review
Apr 23, 2022 · Recent advances in RNA-based therapeutics allow tissue-specific targeting improving safety. Multiple potential target proteins have been identified and RNA-based …See details»
Researchers Refine Lipid Nanoparticles for Enhanced mRNA …
6 days ago · Just as a chef perfects a dish by experimenting with flavors and textures, the researchers used an iterative process, testing variations to find the ideal structure for the …See details»
The landscape for lipid-nanoparticle-based genomic medicines
Jan 10, 2023 · Lipid nanoparticles (LNPs) have recently risen to prominence as the technology platform that enables the delivery of mRNA, the key component of the Moderna and …See details»
LBS 08: Advances in lipid therapeutics | Scientific Sessions
Nov 20, 2024 · LBS 08: Advances in lipid therapeutics. Small-interfering RNA reduced Lp(a) levels, an oral disruptor of Lp(a) synthesis in the liver and selective cholesteryl ester transfer …See details»
Results From KRAKEN and BROOKLYN Studies Help to Advance …
Nov 13, 2024 · Advances in lipid therapeutics were the focus of a late-breaking science session at AHA 2024, with researchers presenting findings evaluating the safety of the novel new drug …See details»
Toward understanding lipid reorganization in RNA lipid ... - PubMed
Oct 30, 2024 · The use of lipid nanoparticles (LNPs) for therapeutic RNA delivery has gained significant interest, particularly highlighted by recent milestones such as the approval of …See details»
Amine headgroups in ionizable lipids drive immune responses to …
Oct 3, 2024 · Here we show that the innate and adaptive immune responses elicited by LNPs are linked to their ionizable lipid chemistry. Specifically, we show that the amine headgroups in …See details»
Nanoparticles for mRNA Delivery Get an Edge via Chemically …
5 days ago · This new method for designing ionizable lipids is expected to have broad implications for mRNA-based vaccines and therapeutics, which are poised to treat a range of conditions, …See details»
Lipid-Lowering Therapies: A Review of Current and Future Options
Feb 12, 2021 · Potentially effective drugs with novel lipid-lowering mechanisms are currently being investigated in clinical trials for use in patients with ASCVD or familial …See details»